Medpage Today on MSN

Year in Review: Breast Cancer

The findings came from analyses of two national cancer registries. ILC accounts for about 10% of all newly diagnosed breast ...
Trastuzumab emtansine is linked to a lower incidence of decrease in left ventricular ejection fraction than other trastuzumab ...
The FDA approved pertuzumab-dpzb (Poherdy) as the first biosimilar for its reference product Perjeta, a monoclonal antibody ...
Endocrine therapy is generally recommended for patients with HR+/HER2-metastatic breast cancer, with the exception of those ...
Dr Christine Lai, a breast cancer and endocrine surgeon in Australia, highlights two foods that increase breast cancer risk. Find out what they are.
Oh the versatile chicken breast. It is a blank canvas that can be flavored so many different ways. Try a simple baked chicken ...
Simone Biles was always planning to publicly address her breast augmentation. Biles, 28, got candid about why she decided to ...
Pertuzumab-dpzb is the first interchangeable biosimilar to pertuzumab, enhancing treatment accessibility for HER2-positive ...
A Disputanta woman says she walked into a local hospital for help with a collapsed breast implant, but ended up undergoing a ...
A naturally-occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of ...
A breast cancer awareness walk in Brownsville drew attention to the lack of health resources in the predominantly minority ...
The U.S. Food and Drug Administration (FDA) approved Poherdy (pertuzumab-dpzb) as the first interchangeable biosimilar to ...